Table 1 Basic characteristics of NMIBC patients
From: The role of TERT C228T and KDM6A alterations and TME in NMIBC treated with BCG
Overall (n = 40) | |
|---|---|
Age | |
Mean (SD) | 62.30 (9.17) |
Median [IQR] | 63.00 [55.75, 68.25] |
Gender (%) | |
Female | 8 (20.0) |
Male | 32 (80.0) |
Stage (%) | |
T1 | 34 (85.0) |
Ta | 5 (12.5) |
Tis | 1 (2.5) |
Grade (%) | |
High grade | 34 (85.0) |
Intermediate | 1 (2.5) |
Low grade | 5 (12.5) |
Tumor percent | |
Mean (SD) | 50.75 (23.90) |
Median [IQR] | 50.00 [37.50, 80.00] |
TMB | |
Mean (SD) | 9.47 (6.62) |
Median [IQR] | 7.98 [4.99, 11.22] |
MSI status (%) | |
MSS | 40 (100.0) |
